GlaxoSmithKline
- Country
- π¬π§United Kingdom
- Ownership
- Public
- Established
- 1929-01-01
- Employees
- 70.2K
- Market Cap
- $90B
- Website
- http://www.gsk.com
- Introduction
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
A Study To Evaluate An NK-1 Antiemetic For The Prevention Of Post Operative Nausea And Vomiting
- Conditions
- Postoperative Nausea and VomitingNausea and Vomiting, Postoperative
- First Posted Date
- 2005-04-14
- Last Posted Date
- 2017-01-20
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 701
- Registration Number
- NCT00108095
- Locations
- πͺπΈ
GSK Investigational Site, Santiago de Compostela, Spain
The CLEVER Study - Coreg And Left Ventricular Mass Regression
- Conditions
- Hypertrophy, Left Ventricular
- Interventions
- First Posted Date
- 2005-04-14
- Last Posted Date
- 2016-12-16
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 287
- Registration Number
- NCT00108082
- Locations
- πΊπΈ
GSK Investigational Site, Milwaukee, Wisconsin, United States
Seasonal Allergic Rhinitis In Pediatric Subjects
- Conditions
- Rhinitis, Allergic, Perennial
- First Posted Date
- 2005-04-08
- Last Posted Date
- 2016-09-15
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 576
- Registration Number
- NCT00107757
- Locations
- πΊπΈ
GSK Investigational Site, Madison, Wisconsin, United States
Anti-Tumor Activity Of SB-485232 In Patients With Previously Untreated Metastatic Melanoma
- Conditions
- Melanoma
- First Posted Date
- 2005-04-08
- Last Posted Date
- 2017-07-27
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 64
- Registration Number
- NCT00107718
- Locations
- π¦πΊ
GSK Investigational Site, Nedlands, Western Australia, Australia
Study Of Lapatinib In Patients With Relapsed Or Refractory Inflammatory Breast Cancer
- First Posted Date
- 2005-03-21
- Last Posted Date
- 2015-09-28
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 126
- Registration Number
- NCT00105950
- Locations
- π¬π§
GSK Investigational Site, London, United Kingdom
Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy
- Conditions
- Nausea and Vomiting, Chemotherapy-InducedChemotherapy-Induced Nausea and Vomiting
- First Posted Date
- 2005-03-01
- Last Posted Date
- 2015-04-16
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 722
- Registration Number
- NCT00104403
- Locations
- π¬π§
GSK Investigational Site, Shrewsbury, United Kingdom
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) Seizures
- Conditions
- Epilepsy, Tonic-Clonic
- Interventions
- Drug: Placebo
- First Posted Date
- 2005-03-01
- Last Posted Date
- 2017-01-02
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 153
- Registration Number
- NCT00104416
- Locations
- πΊπ¦
GSK Investigational Site, Lviv, Ukraine
Study In Subjects With COPD (Chronic Obstructive Pulmonary Disease)
- First Posted Date
- 2005-02-18
- Last Posted Date
- 2016-10-28
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 600
- Registration Number
- NCT00103922
- Locations
- πΊπΈ
GSK Investigational Site, Milwaukee, Wisconsin, United States
Study Of Talnetant Versus Placebo And Risperidone In Schizophrenia
- First Posted Date
- 2005-02-15
- Last Posted Date
- 2015-04-29
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 282
- Registration Number
- NCT00103727
- Locations
- πΊπΈ
GSK Investigational Site, Richmond, Virginia, United States
A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR).
- First Posted Date
- 2005-02-09
- Last Posted Date
- 2016-09-19
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 288
- Registration Number
- NCT00103454
- Locations
- π¨π¦
GSK Investigational Site, Saskatoon, Saskatchewan, Canada